S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
AI healthcare stock poised for 36,996% growth? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
AI healthcare stock poised for 36,996% growth? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
AI healthcare stock poised for 36,996% growth? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Biden replacement revealed? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
AI healthcare stock poised for 36,996% growth? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial

Milestone Pharmaceuticals (MIST) Earnings Date, Estimates & Call Transcripts

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free MIST Stock Alerts
$1.63
-0.12 (-6.86%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 21)
-$0.32 Missed By -$0.02
Consensus EPS
(Mar. 21)
-$0.30
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MIST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Milestone Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.30)($0.30)($0.30)
Q2 20241($0.30)($0.30)($0.30)
Q3 20241($0.35)($0.35)($0.35)

MIST Earnings Date and Information

Milestone Pharmaceuticals last released its quarterly earnings results on March 21st, 2024. The reported ($0.32) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.02. Milestone Pharmaceuticals has generated ($1.39) earnings per share over the last year (($1.39) diluted earnings per share). Earnings for Milestone Pharmaceuticals are expected to decrease in the coming year, from ($1.15) to ($1.54) per share. Milestone Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Milestone Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)		------- 
3/21/2024Q4 2023($0.30)($0.32)($0.02)($0.32)--
11/13/2023Q3 2023($0.38)($0.35)+$0.03($0.35)--
8/10/2023Q2 2023($0.39)($0.37)+$0.02($0.37)--
5/11/2023Q1 2023($0.38)($0.35)+$0.03($0.35)-$1.00 million
3/29/2023Q4 2022($0.35)($0.31)+$0.04($0.31)$3.50 million$3.50 million
11/10/2022Q3 2022($0.41)($0.34)+$0.07($0.34)-$1.50 million
8/10/2022Q2 2022($0.36)($0.39)($0.03)($0.39)--
5/12/2022Q1 2022($0.39)($0.33)+$0.06($0.33)--    
3/24/2022Q4 2021-($0.40)($0.40)($0.40)--
11/12/2021Q3 2021($0.38)($0.34)+$0.04($0.34)--
8/11/2021Q2 2021($0.26)$0.02+$0.28$0.02-$15.00 million
5/16/2021Q1 2021($0.33)($0.30)+$0.03($0.30)--

Milestone Pharmaceuticals Earnings - Frequently Asked Questions

When is Milestone Pharmaceuticals's earnings date?

Milestone Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on MIST's earnings history.

Did Milestone Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Milestone Pharmaceuticals (NASDAQ:MIST) missed the analysts' consensus estimate of ($0.30) by $0.02 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. MIST's actual earnings.

How much revenue does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded annual revenue of $1 million.

How much profit does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded net income of -$59.69 million. MIST has generated -$1.39 earnings per share over the last four quarters.

What is Milestone Pharmaceuticals's EPS forecast for next year?

Milestone Pharmaceuticals's earnings are expected to decrease from ($1.15) per share to ($1.54) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MIST) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
A.I. Pioneer Issues Urgent Warning to Americans
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts